Markets.News

ZLAB  ZAI LAB LTD

+ add to watchlist

$30.76

zai lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. our vision is to address the largest unmet medical needs and transform patients’ lives around the world. we take a unique approach to combine both in-licensed products and internal r&d; to achieve a rich pipeline. we believe our drug candidates can be truly disease modifying and bring significant benefits to patients. the company was founded in 2013 by a group of industry veterans. the founders are known as pioneers in china’s fast advancing biotech industry with a proven track record for successful chinese cfda and us fda filings and approvals. our senior management team introduced fast regulatory approval pathways in china and developed a variety of partnership models with multinational pharmaceutical companies. we endeavor to conduct world class clinical development in china and beyond. zai lab has strong backing from a leading group of healthcare investors. our inve

Mkt Cap: $3.38B

52 Week High: $44.34

P/E: 0.00

52 Week Low: $19.16

Dividend: $0.00

Shares Outstanding: 109.96M

This news is delayed by 15 minutes, sign up now to get live news & full features.